Form 4 Filing for Bone Biologics Corp - Bruce Stroever

Bruce Stroever, a director at Bone Biologics Corp (BBLG), acquired 113,896 shares of Common Stock through the exercise of a Non-Employee Stock Option on September 28, 2026. The option had an exercise price of $0.50 and an expiration date of September 28, 2036. This transaction was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan and vests in four equal quarterly installments. Following this transaction, Stroever directly owns 113,896 shares of Common Stock underlying this option. The filing also details other previously held stock options with varying exercise prices and expiration dates, including options to acquire 10,483 shares at $5.28, 5,119 shares at $10.38, 1,787 shares at $30.72, 26 shares at $2323.58, 7 shares at $5068.80, and 3 shares at $7560.00. All these options are exercisable as of the report date.